DK0471259T3 - Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater - Google Patents

Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater

Info

Publication number
DK0471259T3
DK0471259T3 DK91113089.6T DK91113089T DK0471259T3 DK 0471259 T3 DK0471259 T3 DK 0471259T3 DK 91113089 T DK91113089 T DK 91113089T DK 0471259 T3 DK0471259 T3 DK 0471259T3
Authority
DK
Denmark
Prior art keywords
acid derivatives
aminooxyalkanecarboxylic
phenylsulfonamide
substituted pyridine
reaction
Prior art date
Application number
DK91113089.6T
Other languages
English (en)
Inventor
Erwin Dr Bischoff
Ulrich Dr Niewoehner
Ulrich E Dr Mueller
Elisabeth Dr Perzborn
Hans-Georg Dr Dellweg
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of DK0471259T3 publication Critical patent/DK0471259T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/53—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91113089.6T 1990-08-16 1991-08-03 Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater DK0471259T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4025818A DE4025818A1 (de) 1990-08-16 1990-08-16 Phenylsulfonamid substituierte pyridinalken- und -aminooxyalkancarbonsaeure-derivate

Publications (1)

Publication Number Publication Date
DK0471259T3 true DK0471259T3 (da) 1995-09-11

Family

ID=6412268

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91113089.6T DK0471259T3 (da) 1990-08-16 1991-08-03 Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater

Country Status (7)

Country Link
US (1) US5155121A (da)
EP (1) EP0471259B1 (da)
JP (1) JPH04244063A (da)
AT (1) ATE122657T1 (da)
DE (2) DE4025818A1 (da)
DK (1) DK0471259T3 (da)
ES (1) ES2072492T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1476425A4 (en) * 2002-01-30 2010-05-05 Amgen Inc Heterocyclic Aryl Sulphonamidocyclic Compounds
WO2003099773A1 (en) 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
US7420055B2 (en) * 2002-11-18 2008-09-02 Chemocentryx, Inc. Aryl sulfonamides
US7741519B2 (en) 2007-04-23 2010-06-22 Chemocentryx, Inc. Bis-aryl sulfonamides
DK1798223T4 (da) * 2002-11-18 2014-09-22 Chemocentryx Inc Arylsulfonamider
US20070021466A1 (en) * 2002-11-18 2007-01-25 Solomon Ungashe CCR2 inhibitors and methods of use thereof
US7227035B2 (en) * 2002-11-18 2007-06-05 Chemocentryx Bis-aryl sulfonamides
US20060111351A1 (en) * 2002-11-18 2006-05-25 Solomon Ungashe Aryl sulfonamides
GB0316889D0 (en) * 2003-07-18 2003-08-20 Univ London Pharmaceutical agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3838120A (en) * 1972-12-07 1974-09-24 Sterling Drug Inc 1-alkyl-1h,4h-pyrido(2,3-d)(1,3)oxazine-2,4-diones and their conversion to 1-alkyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids
US4518602A (en) * 1982-10-07 1985-05-21 Takeda Chemical Industries, Ltd. Vinyl carboxylic acid derivatives, their production and use as inhibitors of thromboxane synthetase
US4874775A (en) * 1985-06-11 1989-10-17 Eli Lilly And Company Agriculturally useful sulfonamides
SE501541C2 (sv) * 1987-05-22 1995-03-06 Squibb & Sons Inc Fosforhaltiga HMG-CoA reduktasinhibitorer, nya mellanprodukter och metod
DE3932403A1 (de) * 1989-05-12 1991-04-11 Thomae Gmbh Dr K Neue arylsulfonamide, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
JPH04244063A (ja) 1992-09-01
US5155121A (en) 1992-10-13
DE4025818A1 (de) 1992-02-20
EP0471259B1 (de) 1995-05-17
ATE122657T1 (de) 1995-06-15
EP0471259A1 (de) 1992-02-19
DE59105500D1 (de) 1995-06-22
ES2072492T3 (es) 1995-07-16

Similar Documents

Publication Publication Date Title
NO924433L (no) Isoksazol-4-karboksylsyreamider og hydroksyalkyliden-cyaneddiksyreamider, legemidler inneholdende disse forbindelsene og deres anvendelse
NO944430D0 (no) 4-mercaptoacetylamino-[2Åbenzazepinon(3)-derivater, og anvendelse som enkefalinaseinhibitorer
DK0933993T3 (da) Substituerede cyclopentanforbindelser, der er egnede som neuraminidaseinhibitorer
RO83309A (ro) Procedeu pentru prepararea (-)-n-metil-3-(2-metil-fenoxi)-3-fenilpropilaminei
CY1105085T1 (el) Ενωσεις τυπου ν-φορμυλο υδροξυλαμινης ως αναστολεις της pdf
ES529314A0 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
FI913943A0 (fi) Nya kroman- och tiokromanderivat.
IT8022331A0 (it) Essiccazione o rispettivamente per procedimento per il trattamento la calcinazione. termico, in particolare per la
DK0471259T3 (da) Phenylsulfonamid-substituerede pyridinalken- og -aminooxyalkancarboxylsyre-derivater
ATE128128T1 (de) Antiatherosclerotische und antithrombotische 2- amino-6-phenyl-4h-pyran-4-one.
PT89478A (pt) Processo para a preparacao de piridinas di-substituidas
NO883846L (no) Anvendelse av polyaralkylaminer som korrosjonsinhibitorer, nye polyaralkylaminer og fremgangsmaate til deres fremstilling.
DE69906568D1 (de) Behandlung von hämorrhagischem virusfieber mit protein c
ES2169022T3 (es) Utilizacion de derivados de (piridil-metil-sulfinil)-1-h-bencimidazol para el tratamiento de enfermedades provocadas por helicobacter.
ES2086359T3 (es) R(-)-1-(5-hidroxihexil)-3-metil-7-propilxantina, procedimiento para su preparacion y medicamentos que contienen este compuesto.
DK585984D0 (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
DK491984D0 (da) Diarylindan-1,3-dioner, fremgangsmaade til fremstilling deraf samt farmaceutiske midler indeholdende disse
SE7611952L (sv) Forfarande for framstellning av aroyl-fenylinden- och aroyl-fenylnaftalenderivat anvendbara sasom antifertilitetsmedel
ATE130304T1 (de) Neue alpha-glukosidaseinhibitoren.
ES2061775T3 (es) Derivados de estrobirulina, su obtencion y empleo.
BR7607551A (pt) Processo para preparacao de dispersoes setaveis,dispersoes e sua aplicacao
ES2053541T3 (es) Derivados de tri- o tetra-2-hidroxibencil-1,2-diaminoalcano, un proceso para su preparacion y su empleo en la extraccion de galio.
BR7604541A (pt) Processo para preparacao de gama-pironas,e para producao de compostos,e composicao flavorizante ou aromatica
IT1070801B (it) Processo per la preparazione della 5 amminocarbonil 2,4,6 triidossipirimidina
ES221329Y (es) Cierre perfeccionado para redomas, frasco o analogo.